• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

    57.75 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5
    Open 57.75
    Bid (Size) 57.29 (100)
    Ask (Size) 58.29 (100)
    Prev. Close 57.75
    Today's Range 57.75 - 57.75
    52wk Range 34.08 - 60.44
    Shares Outstanding 388,132,400
    Dividend Yield 1.63%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Royalty Pharma Q2 Earnings Call Highlights ↗
    Royalty Pharma (NASDAQ:RPRX) raised its 2026 outlook for the second consecutive quarter after reporting higher second-quarter royalty receipts, continued capital deployment and progress across its... 
    Via MarketBeat
    Topics Earnings
    Royalty Pharma (NASDAQ:RPRX) Beats Q2 Revenue Estimates, Raises Full-Year Guidance ↗
    Via Chartmill

    Performance

    YTD
    +48.6%
    +48.6%
    1 Month
    +1.5%
    +1.5%
    3 Month
    +13.9%
    +13.9%
    6 Month
    +32.2%
    +32.2%
    1 Year
    +52.3%
    +52.3%

    More News

    Read More
    News headline image
    Royalty Pharma reports second quarter 2026 results
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
    From Royalty Pharma plc
    Via GlobeNewswire
    Royalty Pharma (NASDAQ:RPRX) Beats Q1 Estimates and Raises Guidance, Fueling Strong Momentum ↗
    Via Chartmill
    News headline image
    Royalty Pharma declares third quarter 2026 dividend
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    3 Unpopular Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?
    Via StockStory
    Topics Supply Chain
    News headline image
    Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Mattel Stock Is Down 24%. Here's What a $50.9 Million Exit Could Mean ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions
    Via StockStory
    Topics Earnings
    News headline image
    Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally ↗
    Via The Motley Fool
    News headline image
    This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance Supply Chain
    News headline image
    Royalty Pharma to present at upcoming investor conferences
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma (RPRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Royalty Pharma reports first quarter 2026 results
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Unpopular Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma Declares Second Quarter 2026 Dividend
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
    From Royalty Pharma plc
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
    Via StockStory

    Frequently Asked Questions

    Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
    Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
    What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
    Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
    The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
    What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
    The current price of Royalty Pharma plc - Class A Ordinary Shares is 57.75
    When was Royalty Pharma plc - Class A Ordinary Shares last traded?
    The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 08/05/26 04:00 PM ET
    What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
    The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 22.41B
    How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
    Royalty Pharma plc - Class A Ordinary Shares has 22B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.